sodium sugammadex
PolandDrugs containing this active substance
-
The medicinal product is used to accelerate the recovery of muscle function after surgery, allowing the patient to regain the ability to breathe independently sooner. It works by binding to neuromuscular blocking agents (rocuronium bromide or vecuronium bromide) administered during anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Accord Healthcare Poland Sp. z o.o.
-
The medicine is used to accelerate the recovery of muscle function after surgery, allowing the patient to breathe independently sooner. It works by binding to neuromuscular blocking agents (rocuronium bromide or vecuronium bromide) administered during general anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Combino Pharm Malta Ltd
-
The medicine is used to accelerate the recovery of muscle function after surgery, so that the patient can breathe independently sooner. It works by binding specific neuromuscular blocking agents (rocuronium bromide or vecuronium bromide) that are administered during general anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Delfarma Sp. z o.o. Synthon B.V. Synthon Hispania S.L.
-
It is used to accelerate the recovery of muscle function after surgery, allowing the patient to begin breathing independently sooner. It works by binding to neuromuscular blocking agents (rocuronium bromide or vecuronium bromide) administered during anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Juta Pharma GmbH
-
The medicine is used to accelerate the recovery of muscle function after surgery, allowing the patient to breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) that were administered during anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited
-
The medicinal product is used to accelerate the recovery of muscle function after surgery, allowing the patient to regain the ability to breathe independently sooner. It works by binding to neuromuscular blocking agents (rocuronium bromide or vecuronium bromide) administered during general anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Demo S.A.
-
The medicine is used to accelerate the recovery of muscle function after surgery, so that the patient can breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) that are administered during general anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 100 mg/ml ATC: V03AB35
Manufacturer: Orion Corporation Orion Pharma
-
The medicinal product is used to accelerate the recovery of muscle function after surgery, allowing the patient to breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) administered during general anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Synthon B.V., Synthon Hispania S.L.
-
The medicine is used to accelerate the recovery of muscle function after surgery, so that the patient can breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) that are administered during general anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Betapharm Arzneimittel GmbH
-
The medicine is used to accelerate the recovery of muscle function after surgery, allowing the patient to breathe independently sooner. It works by binding to specific neuromuscular blocking agents (rocuronium bromide or vecuronium bromide) administered during anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Laboratorio Reig Jofre S.A.
-
The medicinal product is used to accelerate the recovery of muscle function after surgery, allowing the patient to regain the ability to breathe independently sooner. It works by binding specific neuromuscular blocking agents (rocuronium bromide or vecuronium bromide) administered during anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 217.6 mg/2 ml ATC: V03AB35
Manufacturer: Lek Pharmaceuticals, d.d.
-
The medicine is used to accelerate the recovery of muscle function after surgery, so that the patient can breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) that were administered during anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Centrafarm Services B.V., STADA Arzneimittel AG, STADA Arzneimittel AG
-
The medicine is used to accelerate the recovery of muscle function after surgery, allowing the patient to breathe independently sooner. It works by binding specific muscle relaxants (rocuronium bromide or vecuronium bromide) administered during anesthesia within the body.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: PLIVA Hrvatska d.o.o. (Pliva Croatia Ltd.)
-
The medicine is used to accelerate the recovery of muscle function after surgery, so that the patient can breathe independently sooner. It works by binding to specific muscle relaxants (rocuronium bromide or vecuronium bromide) that were administered during anesthesia.
Form: solution for injection
Active substance Dosage sodium sugammadex 108.8 mg/ml ATC: V03AB35
Manufacturer: Synthon B.V., Synthon Hispania S.L.